IDEXX Laboratories, Inc.

IDXX · NasdaqGS · Stock · Healthcare
$525.80
+1.05% today
Delayed price,

What IDEXX Laboratories does

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Key facts

Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$41.42B
P/E (ttm)
36.9
Forward P/E
31.4
Dividend yield
0.00%
Beta
1.55
Profit margin
25.0%
Employees
11,000
Headquarters
Westbrook, ME, United States
Exchange
NasdaqGS

Performance

1 Month
+2.8%
3 Months
-7.3%
6 Months
-10.8%
1 Year
-17.2%
5 Years
-13.5%
$500.6152-week range$769.98
Biggest setback — last 12 months
-33.0%
24 Nov 2025 → 7 Sept 2026
Fell from $752.88 to $504.70 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+19.6%
27 Oct 2025 → 24 Nov 2025
Ran from $629.51 to $752.88 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$484.19 (-7.9%)$525.80$570.97 (+8.6%)
3 Months$455.84 (-13.3%)$525.80$606.49 (+15.3%)
6 Months$429.66 (-18.3%)$525.80$643.44 (+22.4%)
12 Months$395.19 (-24.8%)$525.80$699.56 (+33.0%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 28.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.